Summaries & Associations of Study Results
TR-284 Diallyl phthalate
Target Organs and Levels of Evidence
NTP Technical Report Number 284
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| DIALLYL PHTHALATE 131-17-9 |
03/23/84 | FORMS LAMINATES WITH VARIOUS FILLERS (E.G. GLASS CLOTH). ELECTRICAL INSULATION. DYE CARRIER. PRIMARY PLASTICIZER. (TDB) | Gavage 0,50,100 MG/KG/50 PER GROUP | Litton Bionetics, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | LIVER: FIBROSIS, PERIPORTAL; PIGMENTATION; HYPERPLASIA, BILE DUCT | |||
| FR: EQUIVOCAL EVIDENCE | HEMATOPOIETIC SYSTEM: LEUKEMIA 15/50 15/43 25/49 | |||
| NON-NEOPLASTIC LESIONS: | LIVER: FIBROSIS, PERIPORTAL; PIGMENTATION; HYPERPLASIA, BILE DUCT | |||
Web page last updated on February 10, 2006
